Bristol-Myers Squibb Stock

$47.34

1.02% yesterday

NYSE, Jul 14, 10:03 pm CET

ISIN

US1101221083

Symbol

BMY

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Bristol-Myers Squibb Stock price

$47.34

-10.55 18.22% 5Y

NYSE, Closing price Mon, Jul 14 2025

+0.48 1.02%

ISIN

US1101221083

Symbol

BMY

Reports

Quarter | Annual

Index

NYSE Composite, S&P 500

Sector

Health

Industry

Pharmaceuticals

Key metrics

Basic

Market capitalization

$96.3b

Enterprise Value

$134.3b

Net debt

$37.9b

Cash

$11.8b

Shares outstanding

2.0b

Valuation (TTM | estimate)

P/E

17.8 | 7.0

P/S

2.0 | 2.0

EV/Sales

2.8 | 2.9

EV/FCF

10.3

P/B

5.5

Dividends

DPS

$2.42

Yield 1Y | 5Y

5.1% | 3.5%

Growth 1Y | 5Y

4.8% | 7.6%

Payout 1Y | 3Y

-54.9% | 288.3%

Increased

18 Years

Financials (TTM | estimate)

Revenue

$47.6b | $46.7b

EBITDA

$20.3b | $18.4b

EBIT

$12.9b | $17.2b

Net Income

$5.4b | $13.5b

Free Cash Flow

$13.1b

Growth (TTM | estimate)

Revenue

4.6% | -3.3%

EBITDA

2.9% | -9.7%

EBIT

22.5% | 48.8%

Net Income

188.1% | 251.3%

Free Cash Flow

4.6%

Financial Health

Equity Ratio

17.6%

Return on Equity

-54.8%

ROCE

18.9%

ROIC

16.1%

Debt/Equity

2.9

EPS

$2.7

FCF per Share

$6.4

Short interest

1.7%

Employees

34k

Rev per Employee

$1.4m

As a Free StocksGuide user, you can view scores for all 7,007 stocks worldwide.

Get Started for Free Today

Bristol-Myers Squibb Stock Analysis

Unlock Scores for Free

??

32 Analysts have issued a Bristol-Myers Squibb forecast:

10x Buy

31%

20x Hold

63%

More details on Analyst Estimates Including Price Targets

32 Analysts have issued a Bristol-Myers Squibb forecast:

Buy

31%

Hold

63%

Sell

Analyst Estimates with Stock Price Targets

Financial data from Bristol-Myers Squibb

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	47,636 47,636	5% 5% 100%
- Direct Costs	12,057 12,057	10% 10% 25%
Gross Profit	35,579 35,579	3% 3% 75%
- Selling and Administrative Expenses	7,586 7,586	4% 4% 16%
- Research and Development Expense	9,672 9,672	5% 5% 20%
EBITDA	20,261 20,261	3% 3% 43%
- Depreciation and Amortization	7,345 7,345	20% 20% 15%
EBIT (Operating Income) EBIT	12,916 12,916	23% 23% 27%
Net Profit	5,419 5,419	188% 188% 11%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Bristol-Myers Squibb Stock News

Positive

24/7 Wall Street

●

about 21 hours ago

$7.4 Trillion Is in Money Markets Now: When Rates Fall, These High-Yield Blue Chips Will Run

According to Yahoo Finance, the average annual percentage yield for high-yield money market accounts is currently around 4.30%, with some banks offering rates exceeding 5.00%.

Positive

Seeking Alpha

●

4 days ago

Dogs Of The S&P 500: 14 Ideal 'Safer' July Dividend Buys

High-yield S&P 500 stocks can be risky, but 14 "safer" S&P 500 dividend dogs have strong free cash flow to support payouts and are attractive buys. Analyst forecasts suggest top ten S&P 500 dividend dogs could deliver 27% to 53% net gains by July 2026, with lower-than-market volatility. A market correction could make more high-yield stocks fairly priced; currently, only a select few meet the 'd...

Positive

The Motley Fool

●

4 days ago

2 Top Stocks Down 16% and 17% This Year to Buy and Hold

Most people love a bargain; investors do too. Purchasing shares of companies that can perform well over long periods is already pretty exciting, but it's even more so when they can be scooped up from the discount bin.

More Bristol-Myers Squibb News

Company Profile

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Head office	United States
CEO	Christopher Boerner
Employees	34,100
Founded	1933
Website	www.bms.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now